Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 4
2008 6
2009 1
2011 7
2012 4
2013 8
2014 9
2015 5
2016 5
2017 3
2018 2
2019 3
2020 7
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Results by year
Filters applied: . Clear all
Page 1
Vaping and lung cancer - A review of current data and recommendations.
Bracken-Clarke D, Kapoor D, Baird AM, Buchanan PJ, Gately K, Cuffe S, Finn SP. Bracken-Clarke D, et al. Among authors: gately k. Lung Cancer. 2021 Mar;153:11-20. doi: 10.1016/j.lungcan.2020.12.030. Epub 2021 Jan 2. Lung Cancer. 2021. PMID: 33429159 Review.
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.
Collins DM, Madden SF, Gaynor N, AlSultan D, Le Gal M, Eustace AJ, Gately KA, Hughes C, Davies AM, Mahgoub T, Ballot J, Toomey S, O'Connor DP, Gallagher WM, Holmes FA, Espina V, Liotta L, Hennessy BT, O'Byrne KJ, Hasmann M, Bossenmaier B, O'Donovan N, Crown J. Collins DM, et al. Among authors: gately ka. Clin Cancer Res. 2021 Feb 1;27(3):807-818. doi: 10.1158/1078-0432.CCR-20-2007. Epub 2020 Oct 29. Clin Cancer Res. 2021. PMID: 33122343 Free PMC article. Clinical Trial.
Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC.
Moore G, Lightner C, Elbai S, Brady L, Nicholson S, Ryan R, O'Sullivan KE, O'Byrne KJ, Blanco-Aparicio C, Cuffe S, O'Neill M, Heavey S, Finn SP, Gately K. Moore G, et al. Among authors: gately k. Cancers (Basel). 2021 Apr 29;13(9):2139. doi: 10.3390/cancers13092139. Cancers (Basel). 2021. PMID: 33946744 Free PMC article.
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Luszczak S, Kumar C, Sathyadevan VK, Simpson BS, Gately KA, Whitaker HC, Heavey S. Luszczak S, et al. Among authors: gately ka. Signal Transduct Target Ther. 2020 Jan 31;5(1):7. doi: 10.1038/s41392-020-0109-y. Signal Transduct Target Ther. 2020. PMID: 32296034 Free PMC article. Review.
Thymidine Phosphorylase in Cancer; Enemy or Friend?
Elamin YY, Rafee S, Osman N, O Byrne KJ, Gately K. Elamin YY, et al. Among authors: gately k. Cancer Microenviron. 2016 Apr;9(1):33-43. doi: 10.1007/s12307-015-0173-y. Epub 2015 Aug 23. Cancer Microenviron. 2016. PMID: 26298314 Free PMC article. Review.
Targeting the fibroblast growth factor receptor family in cancer.
Hallinan N, Finn S, Cuffe S, Rafee S, O'Byrne K, Gately K. Hallinan N, et al. Among authors: gately k. Cancer Treat Rev. 2016 May;46:51-62. doi: 10.1016/j.ctrv.2016.03.015. Epub 2016 Apr 12. Cancer Treat Rev. 2016. PMID: 27109926 Review.
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC.
Ryan SL, Beard S, Barr MP, Umezawa K, Heavey S, Godwin P, Gray SG, Cormican D, Finn SP, Gately KA, Davies AM, Thompson EW, Richard DJ, O'Byrne KJ, Adams MN, Baird AM. Ryan SL, et al. Among authors: gately ka. Lung Cancer. 2019 Sep;135:217-227. doi: 10.1016/j.lungcan.2019.07.006. Epub 2019 Jul 12. Lung Cancer. 2019. PMID: 31446998
57 results